Real-time enrollment status for this acinetobacter baumannii-calcoaceticus complex infection (abc) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:25 PM UTC
| NCT Number | NCT06801223 |
| Recruiting Status | Recruiting |
| Condition | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Innoviva Specialty Therapeutics |
| Last Updated on CT.gov | October 6, 2026 (6 days ago) |
As of October 12, 2026: Clinical trial NCT06801223 is currently recruiting participants. This phase1 study for acinetobacter baumannii-calcoaceticus complex infection (abc) is actively seeking new participants at 4 locations across the United States. The study is sponsored by Innoviva Specialty Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06801223 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06801223 was last updated 6 days ago (October 6, 2026). HelloStudys verifies this status automatically.